Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
Laila Shalabi, Medical Student at Gharyan Central Hospital, Libya, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Adding a voice to an ongoing clinical debate. While recent meta-analyses favor clopidogrel over aspirin, the nuances of concomitant medications specifically Proton Pump Inhibitors (PPIs) cannot be ignored.
In our Lancet correspondence, we highlighted that while clopidogrel is superior to aspirin, concurrent PPI use significantly attenuates its bleeding and efficacy benefits, making a patient’s medication list a primary determinant of clinical success. We specifically recommended pantoprazole for its better pharmacodynamic profile and called for more targeted research. The authors replied by acknowledging that while PPIs might modify bleeding risk, clopidogrel’s ischemic benefits remain consistent and superior regardless of PPI use.
They further cautioned against overinterpreting subgroup trends where no significant treatment-by-subgroup interaction was observed for cardiovascular outcomes. This dialogue underscores the clinical complexity of antiplatelet therapy in the secondary prevention phase.
I am deeply grateful to my colleague Ahmed Ibrahim for the true teamwork, and to our mentor Prof.Andò for his continuous support and guidance.”
Title: Clopidogrel versus aspirin for coronary artery disease
Authors: Ahmed Ibrahim, Laila Shalabi, Giuseppe Andó
Read the Full Article on The Lancet.
Title: Clopidogrel versus aspirin for coronary artery disease – Authors’ reply
Authors: Marco Valgimiglia, Felice Gragnano, Daniele Giacoppo
Read the Author’s Reply on The Lancet.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 03:31Mostafa Elshazly: How Is Humidification Used During Non Invasive Ventilation?
-
Sep 22, 2026, 03:05Sumyea Kabir: Jehovah’s Witnesses Update Their Position on Blood Components
-
Sep 22, 2026, 02:33Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Sep 21, 2026, 20:56George Touma: ApoB Should Be Central to All Lipid Guidlines
-
Sep 21, 2026, 20:55Christopher Robinson: Obstetric Risks Are Seen at the Extremes of Birthweight
-
Sep 21, 2026, 20:54Emicizumab for Refractory GI Bleeding in Myeloma-Associated Acquired VWD – JTH
-
Sep 21, 2026, 20:52Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders
-
Sep 21, 2026, 20:50Rainer Kaiser: Genes and Signalling Pathways Implicated in Procoagulant Platelet Generation
-
Sep 21, 2026, 20:49Natalia Dovlatova: Celebrating Stan Heptinstall and His Legacy in Platelet Science